Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 34 Pancreatic Neoplasms 14 Neuroblastoma 13 Neoplasm Metastasis 11 Stomach Neoplasms 9 Neoplasms 8 Rectal Neoplasms 5 Small Cell Lung Carcinoma 4 Esophageal Squamous Cell Carcinoma 4 Colonic Neoplasms 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Ovarian Neoplasms 3 Gastrointestinal Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Wilms Tumor 2 Sarcoma 2 Recurrence 2 Osteosarcoma 2 Ganglioneuroblastoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Biliary Tract Neoplasms 2 Adenocarcinoma Of Esophagus 2 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Solid Tumors 1

Interventions

pembrolizumab 6 cabozantinib 6 Nivolumab 5 Ipilimumab 5 Axitinib 5 Radiosurgery 3 Blood Specimen Collection 3 zimberelimab 2 lenvatinib 2 Ultrasonography 2 Radiotherapy 2 Biopsy 2 tislelizumab 1 polyethylene glycol 3350 1 pazopanib 1 palbociclib 1 orellanine 1 olaparib 1 gallium Ga 68 dotatate 1 fludarabine 1 cyclopropapyrroloindole 1 brodalumab 1 belzutifan 1 atezolizumab 1 anlotinib 1 adagrasib 1 Watchful Waiting 1 Vincristine 1 Therapeutics 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Kidney Neoplasms × Irinotecan × Clear all

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡